McGowan Group Asset Management’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-650
Closed -$203K 131
2025
Q2
$203K Sell
650
-114
-15% -$43.6K 0.03% 124
2025
Q1
$400K Buy
764
+1
+0.1% +$511 0.05% 88
2024
Q4
$386K Sell
763
-147
-16% -$83.5K 0.05% 93
2024
Q3
$532K Buy
910
+10
+1% +$5.66K 0.07% 73
2024
Q2
$458K Buy
900
+58
+7% +$28.4K 0.06% 78
2024
Q1
$416K Sell
842
-21
-2% -$10.7K 0.06% 88
2023
Q4
$455K Sell
863
-2
-0.2% -$1.07K 0.07% 79
2023
Q3
$436K Buy
865
+139
+19% +$68.4K 0.07% 82
2023
Q2
$349K Buy
726
+38
+6% +$18.6K 0.05% 103
2023
Q1
$325K Sell
688
-41
-6% -$19.8K 0.05% 102
2022
Q4
$387K Hold
729
0.06% 90
2022
Q3
$368K Buy
729
+13
+2% +$6.84K 0.06% 80
2022
Q2
$368K Sell
716
-28
-4% -$14.1K 0.06% 82
2022
Q1
$379K Buy
744
+61
+9% +$29.4K 0.06% 82
2021
Q4
$343K Buy
683
+77
+13% +$34.9K 0.06% 91
2021
Q3
$237K Buy
606
+24
+4% +$9.94K 0.04% 101
2021
Q2
$233K Buy
582
+23
+4% +$9.17K 0.04% 101
2021
Q1
$208K Buy
+559
New +$194K 0.03% 104

Other funds holding UNH

McGowan Group Asset Management's UNH Position: Q3 2025 in Review

McGowan Group Asset Management sold out of UnitedHealth (UNH) in Q3 2025, closing a stake of 650 shares — an estimated $203K sold.

McGowan Group Asset Management first reported a position in UNH in Q1 2021 and held it in 18 quarters. The position peaked at $532K in Q3 2024. 3,159 funds tracked by Wall St. Rank hold UNH as of Q3 2025.

  • McGowan Group Asset Management reported no remaining UnitedHealth position as of Q3 2025 after selling out during the quarter.
  • McGowan Group Asset Management sold 650 UnitedHealth shares in Q3 2025, an estimated $203K.
  • McGowan Group Asset Management first reported a position in UnitedHealth in Q1 2021 and held it in 18 quarters.
  • McGowan Group Asset Management's UnitedHealth position peaked at $532K in Q3 2024.
  • 3,159 funds tracked by Wall St. Rank held UnitedHealth as of Q3 2025.

Based on McGowan Group Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.